E. M. Steen-Banasik

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

H. Putter, T. Bosse, B. van Triest, 2018, British Journal of Cancer.

Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study.

C. Kirisits, R. Pötter, C. Haie-meder, 2020, Gynecologic oncology.